CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

FARALLON CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000909661)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 6,933,098 Value ($000) $322,736 Avg Close $44.52 Range $38.81 - $50.98
Q3 2025
Shares 5,770,098 Value ($000) $240,325 Avg Close $31.97 Range $25.83 - $47.41
Q2 2025
Shares 4,646,098 Value ($000) $133,622 Avg Close $30.88 Range $24.10 - $34.68
Q1 2025
Shares 4,605,098 Value ($000) $154,455 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 4,075,098 Value ($000) $208,360 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 1,162,000 Value ($000) $59,378 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 497,000 Value ($000) $22,261 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 5,000 Value ($000) $234 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 122,904 Value ($000) $4,373 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 361,904 Value ($000) $10,763 Avg Close $20.61 Range $15.76 - $31.00
Q4 2018
Shares 95,365 Value ($000) $2,860 Avg Close $28.15 Range $20.13 - $36.95
Q3 2018
Shares 141,815 Value ($000) $4,063 Avg Close $29.69 Range $19.23 - $42.00